Watson Inventory Reserves Reflect Delayed Launch Of Wellbutrin SR Generics
Executive Summary
Watson is taking an inventory reserve to account for the delayed launch of its "authorized" generic of GlaxoSmithKline's Wellbutrin SR (bupropion sustained-release)
You may also be interested in...
Eon Wellbutrin SR Generic Launch Blocked By Preliminary Injunction
GlaxoSmithKline will post a $3 mil. bond as part of a preliminary injunction the company obtained preventing the launch of Eon's 100 mg generic version of Wellbutrin SR
Eon Wellbutrin SR Generic Launch Blocked By Preliminary Injunction
GlaxoSmithKline will post a $3 mil. bond as part of a preliminary injunction the company obtained preventing the launch of Eon's 100 mg generic version of Wellbutrin SR
Eon Wellbutrin SR Generic Launch Could Slow GSK Conversion Efforts
Eon's launch of generic bupropion extended-release (Wellbutrin SR) should allow it to grab significant market share before GlaxoSmithKline fully converts SR patients to once-daily Wellbutrin XL